BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1090 related articles for article (PubMed ID: 28409830)

  • 41. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
    Okomo U; Meremikwu MM
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005406. PubMed ID: 17443589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease.
    Goldman RD; Mounstephen W; Kirby-Allen M; Friedman JN
    Pediatrics; 2013 Dec; 132(6):e1634-41. PubMed ID: 24276838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
    Okomo U; Meremikwu MM
    Cochrane Database Syst Rev; 2015 Mar; (3):CD005406. PubMed ID: 25764071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydroxyurea for sickle cell disease.
    Davies S; Olujohungbe A
    Cochrane Database Syst Rev; 2001; (2):CD002202. PubMed ID: 11406036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
    Okomo U; Meremikwu MM
    Cochrane Database Syst Rev; 2012 Jun; (6):CD005406. PubMed ID: 22696351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laser therapy for retinopathy in sickle cell disease.
    Myint KT; Sahoo S; Thein AW; Moe S; Ni H
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010790. PubMed ID: 26451693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Fortin PM; Trivella M; Hopewell S
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003149. PubMed ID: 27049331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatments for priapism in boys and men with sickle cell disease.
    Chinegwundoh FI; Smith S; Anie KA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004198. PubMed ID: 28926088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phytomedicines (medicines derived from plants) for sickle cell disease.
    Cordeiro NJ; Oniyangi O
    Cochrane Database Syst Rev; 2004; (3):CD004448. PubMed ID: 15266534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
    Ng SM; Stepien KM; Krishan A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH; Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009191. PubMed ID: 23543572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Wang WC; Dwan K
    Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
    Okomo U; Meremikwu MM
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD005406. PubMed ID: 28759112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood transfusions for treating acute chest syndrome in people with sickle cell disease.
    Dastgiri S; Dolatkhah R
    Cochrane Database Syst Rev; 2016 Aug; (8):CD007843. PubMed ID: 27574910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatments for priapism in boys and men with sickle cell disease.
    Chinegwundoh FI; Smith S; Anie KA
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004198. PubMed ID: 32251534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH; Nagalla S
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD009191. PubMed ID: 34932828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.